Literature DB >> 17440159

Liver cancer biomarkers struggling to succeed.

Steve Benowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17440159     DOI： 10.1093/jnci/djk174

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.

Authors:  Ning Ai; Wei Liu; Zhi-Gang Li; Hong Ji; Bo Li; Guang Yang
Journal:  Oncol Lett       Date:  2017-08-01       Impact factor: 2.967

2.  Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.

Authors:  Wen-Wei Zhu; Jia-Jian Guo; Lei Guo; Hu-Liang Jia; Ming Zhu; Ju-Bo Zhang; Christopher A Loffredo; Marshonna Forgues; Hua Huang; Xu-Jian Xing; Ning Ren; Qiong-Zhu Dong; Hai-Jun Zhou; Zheng-Gang Ren; Nai-Qing Zhao; Xin Wei Wang; Zhao-You Tang; Lun-Xiu Qin; Qing-Hai Ye
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

3.  HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City.

Authors:  Rafael Guerrero-Preston; Abby Siegel; John Renz; David Vlahov; Alfred Neugut
Journal:  J Community Health       Date:  2009-12

4.  Serum levels of soluble CD25 as a marker for hepatocellular carcinoma.

Authors:  Roniel Cabrera; Asem I Fitian; Miguel Ararat; Yiling Xu; Todd Brusko; Clive Wasserfall; Mark A Atkinson; Chen Liu; David R Nelson
Journal:  Oncol Lett       Date:  2012-07-26       Impact factor: 2.967

Review 5.  Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.

Authors:  De-Leung Gu; Yen-Hsieh Chen; Jou-Ho Shih; Chi-Hung Lin; Yuh-Shan Jou; Chian-Feng Chen
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

6.  Flow injection/sequential injection analysis systems: potential use as tools for rapid liver diseases biomarker study.

Authors:  Supaporn Kradtap Hartwell
Journal:  Int J Hepatol       Date:  2012-03-18

7.  Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.

Authors:  Jing Yang; Jingjing Li; Weiqi Dai; Fan Wang; Miao Shen; Kan Chen; Ping Cheng; Yan Zhang; Chengfen Wang; Rong Zhu; Huawei Zhang; Yuanyuan Zheng; Junshan Wang; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

8.  Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.

Authors:  Wenjun Liao; Yilei Mao; Penglei Ge; Huayu Yang; Haifeng Xu; Xin Lu; Xinting Sang; Shouxian Zhong
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

9.  Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.

Authors:  Yu Jin; Ye Shen Wong; Brian K P Goh; Chung Yip Chan; Peng Chung Cheow; Pierce K H Chow; Tony K H Lim; George B B Goh; Thinesh Lee Krishnamoorthy; Rajneesh Kumar; Tze Pin Ng; Samuel S Chong; Hwee Huang Tan; Alexander Y F Chung; London Lucien P J Ooi; Jason P E Chang; Chee Kiat Tan; Caroline G L Lee
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

10.  TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma.

Authors:  Yong Li; Junjun Wu; Enliang Li; Zhouqing Xiao; Jun Lei; Fan Zhou; Xiangbao Yin; Dandan Hu; Yilei Mao; Linquan Wu; Liao Wenjun
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.